Development of Platelet-Targeted Nanoparticles for Magnetic Resonance Imaging towards the Detection of Thrombi/Emboli and Vulnerable Atherosclerotic Plaques
Development of Platelet-Targeted Nanoparticles for Magnetic Resonance Imaging towards the Detection of Thrombi/Emboli and Vulnerable Atherosclerotic Plaques
批准号:
nhmrc : 1017670
负责人:
A/Pr Christoph Hagemeyer
金额:
$40.44万
依托单位国家:
澳大利亚
项目类别:
NHMRC Development Grants
财政年份:
2011
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2011-01-01 至 2013-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Heart attack, stroke and pulmonary embolism typically strike without warning and either kill patients or cause devastating disabilities. Currently, we do not have diagnostic methods to identify patients and the blood vessels at risk. We have developed a new innovative MRI nanoparticle directed against activated platelets for the detection of _at risk� blood vessels. The current funding is requested to optimise the manufacture of this targeted MRI nanoparticle and to undertake the animal studies required to enter early stage clinical trials.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Smart targeted nanoparticles for diagnosis and therapy
-
批准号:nhmrc : GNT1154270
-
项目类别:Research Fellowships
-
资助金额:$72.42万
-
财政年份:2019
-
负责人:A/Pr Christoph Hagemeyer
-
依托单位:
Degradable nanocapsules for thromboprophylaxis and treatment of acute thrombosis
-
批准号:nhmrc : GNT1138361
-
项目类别:Project Grants
-
资助金额:$115.84万
-
财政年份:2018
-
负责人:A/Pr Christoph Hagemeyer
-
依托单位:
Degradable nanocapsules for thromboprophylaxis and treatment of acute thrombosis
-
批准号:nhmrc : 1138361
-
项目类别:Project Grants
-
资助金额:$78.33万
-
财政年份:2018
-
负责人:A/Pr Christoph Hagemeyer
-
依托单位:
Molecular imaging and therapy of cardiac fibrosis in atrial fibrillation and heart failure
-
批准号:nhmrc : 1120129
-
项目类别:Project Grants
-
资助金额:$68.96万
-
财政年份:2017
-
负责人:A/Pr Christoph Hagemeyer
-
依托单位:
Molecular imaging and therapy of cardiac fibrosis in atrial fibrillation and heart failure
-
批准号:nhmrc : GNT1120129
-
项目类别:Project Grants
-
资助金额:$102.17万
-
财政年份:2017
-
负责人:A/Pr Christoph Hagemeyer
-
依托单位:
Preclinical development of a therapeutic anticancer antibody to c-Met
-
批准号:nhmrc : 1113743
-
项目类别:Development Grants
-
资助金额:$29.04万
-
财政年份:2016
-
负责人:A/Pr Christoph Hagemeyer
-
依托单位:
Delivering nanoparticles to prevent rupture of unstable arterial plaques
-
批准号:nhmrc : 1078118
-
项目类别:Project Grants
-
资助金额:$40.92万
-
财政年份:2015
-
负责人:A/Pr Christoph Hagemeyer
-
依托单位:
Delivering nanoparticles to prevent rupture of unstable arterial plaques
-
批准号:nhmrc : GNT1078118
-
项目类别:Project Grants
-
资助金额:$59.38万
-
财政年份:2015
-
负责人:A/Pr Christoph Hagemeyer
-
依托单位:
Antibody targeted thrombin-activatable ?-plasminogen fusion proteins and nanocapsules for the treatment of acute thrombosis
-
批准号:nhmrc : 1028145
-
项目类别:Project Grants
-
资助金额:$35.8万
-
财政年份:2012
-
负责人:A/Pr Christoph Hagemeyer
-
依托单位:
Sortase Peptide Technology: Enzymatic Site-specific Bioconjugation to Improve Antibody Drug Conjugate Production and Performance
-
批准号:nhmrc : 1039017
-
项目类别:Development Grants
-
资助金额:$26.81万
-
财政年份:2012
-
负责人:A/Pr Christoph Hagemeyer
-
依托单位:
Novel 18F and 64Cu labelled targeted nanoparticles for molecular positron emission tomography: A means for early and sensitive detection of thrombosis, inflammation and vulnerable, rupture-prone atherosclerotic plaques
-
批准号:nhmrc : 1029249
-
项目类别:Project Grants
-
资助金额:$38.2万
-
财政年份:2012
-
负责人:A/Pr Christoph Hagemeyer
-
依托单位:
Single-chain antibodies for directed stem cell homing and targeting of effector cells in vascular disease
-
批准号:nhmrc : 472667
-
项目类别:NHMRC Project Grants
-
资助金额:$39.79万
-
财政年份:2008
-
负责人:A/Pr Christoph Hagemeyer
-
依托单位:
Novel Single-chain antibody-targeted nanoparticles for diagnosis of vascular diseases
-
批准号:nhmrc : 472668
-
项目类别:Career Development Fellowships
-
资助金额:$25.38万
-
财政年份:2008
-
负责人:A/Pr Christoph Hagemeyer
-
依托单位:
海外基金